Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07218198 · ClinicalTrials.gov registry record · NA
Clinical Decision Support Tool for the Treatment of Uncontrolled Hypertension
A NA study, sponsored by The Cleveland Clinic.
- Not yet
- Registry status
- NA
- Development phase
- 168
- Enrollment target
NCT07218198 is a NA study that has not yet begun recruiting, run by The Cleveland Clinic. The registered enrollment target is 168 participants.
The verdict
NCT07218198, a NA study, has not yet begun recruiting, sponsored by The Cleveland Clinic.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 168 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to study whether having a clinical decision support (CDS) tool available to clinician use will more effectively lower BP 4 weeks after an outpatient visit compared with usual care. The main objective is to assess the impact of the CDS tool, that is embedded with the electronic medical record (EMR), that is available during outpatient clinical encounters, on blood pressure (BP) changes among participants with uncontrolled hypertension. Participants will: Visit the clinic 4 weeks, after their initial clinician visit, for a BP check.
Interventions
- OTHER Standard medical treatment
- OTHER Clinical Decision Support Tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2027-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07218198
The ClinicalTrials.gov registry entry for NCT07218198 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard medical treatment is the first listed.
NCT07218198 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07218198 about?
NCT07218198 is a clinical study titled "Clinical Decision Support Tool for the Treatment of Uncontrolled Hypertension". The goal of this clinical trial is to study whether having a clinical decision support (CDS) tool available to clinician use will more effectively lower BP 4 weeks after an outpatient visit compared with usual care. The main objective is to assess the impact of the CDS tool, that is embedded with th...
What is the current status of trial NCT07218198?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 168 participants. The study started on 2026-07-01. Estimated completion is 2027-12-01.
What interventions are being tested in trial NCT07218198?
The interventions under investigation include: Standard medical treatment (OTHER), Clinical Decision Support Tool (OTHER).
Who is sponsoring clinical trial NCT07218198?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.